Stada, an international generic pharmaceutical company, focuses on products with off-patent active pharmaceutical ingredients. The company’s business model relies on organic growth supported by acquisitions with a focus on high growth emerging markets with high branded product segment.
The following figure shows the level of partnering by Stada in the last few years. Being the only independent generics producer in Germany and having a strong presence in Europe, Stada partners to market branded products.
Figure 1: Stada partnering deals 2005-2013
Source: Current Agreements, 2013
Further analysis of the partnering deals shows a strong emphasis on partnerships in areas of CNS, cardiovascular, gastrointestinal, genitourinary and hemtaology.
The following table provides an overview of the partnering deals announced by Stada based on therapy area disclosed. Our report provides more detailed insight into the precise therapeutic target of each deal. See: Partnering Agreements with Stada 2005-2013
Figure 2: Stada partnering deals by therapy area 2005-2013
Source: Current Agreements, 2013
The following table provides an overview of the partnering deals announced by Stada based on deal type disclosed. Most of the partnerships entered by Stada are licensing, asset purchase and distribution agreements for generic and branded products in the international markets.
Figure 3: Stada partnering deals by deal type 2005-2013
Source: Current Agreements, 2013
Further analysis of these deals shows that Stada has a preference for marketed and formulation deals. Stada focuses on development and marketing of active ingredients that are free of IP rights.
The following table provides an overview of the partnering deals announced by Stada based on stage of development at signature
Figure 4: Stada partnering by stage of development 2005-2013
Source: Current Agreements, 2013
The following provides two of the top deals by headline value signed by Stada
Figure 5: Top Stada partnering deals by headline value 2005-2013
Source: Current Agreements, 2013
Our report provides more detailed insight into the details of each deal. See: Partnering Agreements with Stada 2005-2013
Stada partnering at Current Agreements
View all partnering deals for Stada: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
Full details on each deal can be found at CurrentAgreements (subscription required)
Or purchase report: Partnering Agreements with Stada 2005-2013
More
Summary profile data for STADA
Partnering interests for STADA
Available reports from Current Partnering
Report: Partnering Agreements with Stada 2005-2013
Report: Partnering Deals and Alliances with Big Pharma
Available resources for deal coverage for Stada
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
Read: more on Stada company profile, recent partnering, M&A and financing news and articles
Related
Report: Practical Guide to Finding Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk
Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter
